Webinar - Theranostics and PET Imaging Diagnostics
What will you learn from the webinar ?
- Use of PET Imaging companion radiopharmaceutical in theranostics - By Dr. Lisa Bodei
Dr Bodei will give an introduction on the use of PET radiopharmaceuticals in Theranostic applications and she will provide a synopsis of the major clinical trials. She will also share future perspectives in this field.
- Evolving evidence-base for PSMA Theranostics to improve outcomes for men with prostate cancer - By Prof. Michael Hofman
Prof. Hofman will deep dive into PSMA theranostics, a new treatment platform for men with advanced prostate cancer. He will explore the evolving evidence base, discuss different methodologies for patient selection and treatment logistics.
Dr. Lisa Bodei
MD, PhD Lisa Bodei, MD, PhD, Director of Targeted Radionuclide Therapy, Molecular Imaging and Therapy Service, Department of Radiology at Memorial Sloan Kettering Cancer Center.
Prof. Michael Hofman
Professor Michael Hofman, nuclear medicine physician at the Peter MacCallum Cancer Centre in Melbourne.